Aging of the liver: proteolysis of oxidatively modified glutamine synthetase. 1995

J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
Laboratory of Biochemistry, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

During aging cells accumulate altered forms of proteins, notably oxidatively modified proteins. The multicatalytic protease selectively degrades oxidized proteins, suggesting that the age-related accumulation of oxidized proteins might be a consequence of decreased activity of this protease. The protease activity of liver homogenates was assayed with an improved fluorimetric method, using oxidatively modified glutamine synthetase as substrate. Application of this assay to extracts from liver of Fischer 344 rats from both Japan and the United States demonstrated a marked preference for the oxidized substrates, as expected. Extracts from animals ages 8 to 26 months maintain both total proteolytic activity and the ability to distinguish between native and oxidized substrates. Oxidatively modified hepatocyte extracts were also employed as substrate, and older animals again maintained proteolytic activity. The multicatalytic protease was purified from liver of young and old rats, and the specific activity of the preparations were comparable when assayed with oxidatively modified glutamine synthetase. We conclude that the intrinsic neutral or alkaline proteolytic activity of rat liver is maintained during aging.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D009097 Multienzyme Complexes Systems of enzymes which function sequentially by catalyzing consecutive reactions linked by common metabolic intermediates. They may involve simply a transfer of water molecules or hydrogen atoms and may be associated with large supramolecular structures such as MITOCHONDRIA or RIBOSOMES. Complexes, Multienzyme
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D003546 Cysteine Endopeptidases ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
D005974 Glutamate-Ammonia Ligase An enzyme that catalyzes the conversion of ATP, L-glutamate, and NH3 to ADP, orthophosphate, and L-glutamine. It also acts more slowly on 4-methylene-L-glutamate. (From Enzyme Nomenclature, 1992) EC 6.3.1.2. Glutamine Synthetase,Glutamate Ammonia Ligase (ADP),Glutamate Ammonia Ligase,Ligase, Glutamate-Ammonia,Synthetase, Glutamine
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging

Related Publications

J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
December 1986, Experimental eye research,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
January 1985, The Journal of biological chemistry,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
October 1985, The Journal of biological chemistry,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
February 1996, Biological & pharmaceutical bulletin,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
October 1991, Journal of biochemistry,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
September 1984, Biochemistry,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
April 1981, Proceedings of the National Academy of Sciences of the United States of America,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
May 1988, The Journal of biological chemistry,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
May 2002, Free radical biology & medicine,
J A Sahakian, and L I Szweda, and B Friguet, and K Kitani, and R L Levine
January 1994, Methods in enzymology,
Copied contents to your clipboard!